Use of palliative care rising in metastatic lung cancer

  • Huo J & al.
  • Cancer
  • 26 Aug 2019

  • curated by Kelli Whitlock Burton
  • Univadis Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • The proportion of patients with metastatic NSCLC receiving palliative care rose >8-fold between 2001 and 2013.

Why this matters

  • The American Society of Clinical Oncology recommends palliative care for all patients with advanced cancer.

Study design

  • 69,414 patients aged ≥65 years with newly diagnosed metastatic NSCLC between 2001 and 2013 from the Surveillance, Epidemiology, and End Results-Medicare database.
  • Funding: None disclosed.

Key results

  • Overall, 14.9% of patients received palliative care within 1 year of diagnosis.
  • Proportion of patients receiving palliative care rose from 3.6% to 31.9% during the study period (Ptrend<.001 with increases observed all racial and age groups>trend<.001>
  • Receipt of palliative care was significantly more likely in people diagnosed in 2013 vs 2011 (aOR, 12.65; P<.001 p blacks hispanics and other racial groups>
  • ~53.5% received care in a hospital, 27.6% in an outpatient clinic, 13.3% in hospice, 3.2% in a skilled nursing facility, and 2.4% at home.
  • 18.7% of patients received palliative care in multiple settings within 1 year of diagnosis.

Limitations

  • Study did not include patients 1 year of diagnosis.